Prescient Therapeutics locks in two licences for new cell therapy tech

Posted on May 27, 2020 — Jessica Jones Gupta

Anti-cancer biotech company Prescient Therapeutics (PTX) has received two key licences to build a new cell therapy platform. Prescient revealed today it has received an exclusive licence from the University of Pennsylvania for a universal immune cell receptor technology platform invented at the university. Read more on The Market Herald

An interview with Nikil Ragav of InventXYZ on I-Corps and the President’s Innovation Prize.

Posted on — Jessica Jones Gupta

Nikil Ragav’s senior year at Penn was an exciting one. It started with him taking the I-Corps course in the fall,  leveraging that experience and expanding his startup over winter, to then winning the President’s Innovation Prize in the spring. Only a few weeks after winning the Innovation Prize, Nikil was a guest speaker in…

This Penn startup uses ‘ethical AI’ to avoid racial profiling in shoplifting monitoring

Posted on May 14, 2020 — Jessica Jones Gupta

Percepta, a year-old security startup out of University of Pennsylvania, is making moves this summer — namely in that four of its five cofounders are graduating from undergrad next week and are joining the Pennovation Accelerator in September to take next steps with business and development of their AI-based retail security product. The tech uses what the cofounders…

Spring 2020 Penn I-Corps celebrates graduates and launch of a virtual program

Posted on — Jessica Jones Gupta

The spring 2020 Penn I-Corps training was a success despite the logistical challenges faced by the teams and I-Corps program staff due to COVID-19. The cohort got underway right when the COVID-19 pandemic resulted in the Penn campus closing. In previous sessions, each of the I-Corps teams would meet in person over five weeks to…

Fur-baby sick? Wharton MBA launches start-up, taking telemedicine to pets’ parents.

Posted on — Jessica Jones Gupta

My Virtual Veterinarian, a startup that participated in the Penn ICorps program last fall, won Wharton Entrepreneurship’s entrepreneurship competition this year. The competition was done virtually amid the COVID-19 health crisis. Read more on the Philadelphia Inquirer

Spinout Stories: Quantitative Radiology Solutions

Posted on May 12, 2020 — Jessica Jones Gupta

This year, PCI will be highlighting a few of the impressive companies that have spun out from research or technologies invented at the University of Pennsylvania. These companies formed by leveraging the programs of PCI Ventures and their team of experts in the field of company formation, executive recruitment, strategic advising, and multifaceted fundraising.  …

Nine Philly companies on the cutting edge of cell and gene therapy innovation

Posted on May 11, 2020 — Jessica Jones Gupta

The list from Philadelphia Magazine includes five Penn spinouts: Cabaletta Bio, Carisma Therapeutics, Passage Bio, Spark Therapeutics and Tmunity Therapeutics. Read the full article

Headway, a communication device for minimally invasive surgery, wins 2020 Pennvention Grand Prize

Posted on — Jessica Jones Gupta

Now in its fifteenth year, Pennvention prides itself on being the sole Penn entrepreneurship competition with a primary focus on technological innovation. Over the course of the competition, entrants pitch an idea, develop a product, receive help from mentors and enter to win over $20,000 in prizes. This year’s winner was Headway, a wearable device for…

Nikil Ragav wants to bring high-tech, hands-on learning to all students

Posted on May 8, 2020 — Jessica Jones Gupta

“The goal is to provide this type of learning to every school in America regardless of its location or income level of its students, especially in underserved communities.” – Nikil Ragav winner of the Penn President’s Innovation Prize and fall 2019 I-Corps graduate.   Read more on Penn Today

Exciting expansion of Penn startup Passage Bio with Penn’s Gene Therapy Program led by Dr. Jim Wilson

Posted on May 7, 2020 — Jessica Jones Gupta

Passage Bio emerged early last year with a sizable war chest, five gene therapy programs from the University of Pennsylvania and the option to license seven more. Now, the company is doubling down on that partnership, promising the university $5 million a year in exchange for access to more programs and new technologies that come out of…